Assert-IQ ICM

Designed to Outperform, Built to Outlast

Assert-IQ™ Insertable Cardiac Monitor (ICM) is an advanced ICM, sometimes referred to as a loop recorder, which provides efficient, accurate, and continuous patient monitoring. 

This next-gen ICM delivers meaningful value in the areas that are most important:

  • Extended battery longevity with full functionality and no compromises.
  • Clinically actionable data with reduced false positives.2-5
  • Clear, crisp EGMs for improved visualization of P-waves.6
  • 1.5 Tesla (T) and 3T MR Conditional.

Whether you are a healthcare provider or a patient, Assert-IQ ICM offers an innovative solution for monitoring cardiac activity, delivering reliable data, and enabling better care decisions.2-8

Longest Lasting Bluetooth® ICM8-15

Assert-IQ ICM is a Bluetooth®-enabled ICM that provides reliable, long-lasting cardiac monitoring with no compromises in features.

We offer two battery life options to suit different monitoring needs:

Assert-IQ™ 3/3+ | May be Preferred for Traditional Cardiac Monitoring.

3 years1 may be preferred for more traditional reasons for monitoring, such as diagnosing syncope, palpitations, or detection of atrial fibrillation (AF) within cryptogenic stroke patients.

Assert-IQ™ EL+ | Longer Term Monitoring; May be Preferred for AF Management.

≥ 6 years1 may be preferred for longer term monitoring, such as those undergoing therapy and at risk of developing further arrhythmias such as AF.

Clinically Actionable Data

Assert-IQ ICM is an innovative medical device designed to provide industry-leading accuracy for arrhythmia detection. Advanced algorithms build user confidence in transmitted data and provide reassurance to patients who need diagnosis by removing false positives. Each new enhancement for algorithm detection has been tested and proven to reduce false detections.2,3

Enhanced algorithms reduce false detections by 98.7% for AF and Pause while maintaining 97.7% of true EGMs.2,3

New 5-step AF detection discriminator for R-R interval patterns and P-waves in EGMs to verify if an event is true or false.

Key Episode* technology provides flexibility for data management while maintaining time-to-diagnosis for patients. Key Episodes* are uniquely programmed for each arrhythmia type based on evaluation criteria that remove false positives versus a standard set of criteria for episode management. The feature can be toggled on/off as needed.

New IQ Insights

IQ Insights provide trends and timelines of clinically relevant information to empower data-driven decisions. Assert-IQ ICM provides a holistic view for patient management with new intelligent diagnostics:

Premature Ventricular Contractions (PVCs)

Leading PVC detection algorithm offers the ability to capture consecutive events, including couplets and triplets.7

Elevated Heart Rate with and without Activity

An ICM first.8-15

Body Position & Posture Changes

Assess new patient factors to help adjudicate episodes.

Direct Trend Viewer

Assess AF Burden, PVCs, Activity Trends,  and MORE!

Remote Programming

Assert-IQ ICM offers simple and secure remote programming, allowing healthcare professionals to control any connected device remotely. Clinicians can adjust device settings, optimize performance, and eliminate unnecessary alerts or transmissions without requiring patients to visit the clinic physically.**

By leveraging the power of remote programming, healthcare providers can reduce clinic workflow burden and ensure data unique to the patient is transmitted.

Remote Programming Flowchart

All parameters can be remotely programmed by the clinician.***

References

 As of 12.31.22. Reveal LINQ User Manual, LUX-Dx User Manual, LUX-Dx II/II+ User Manual, BIOMONITOR III User Manual, BIOMONITOR IIIm User Manual, and BIOMONITOR IV User Manual.

*Key Episodes is a feature of Merlin.net™ Patient Care Network (PCN)

**Available on DM5300/DM5500

***Not applicable for Name, DOB, and Reason for Monitoring

  1. Data on File. Abbott - Report 90984075. 
  2. Gopinathannair R, Shehata MM, Afzal MR, et al. Novel Algorithms Improve Arrhythmia Detection Accuracy in Insertable Cardiac Monitors. Journal of Cardiovascular Electrophysiology. 2023;34(9):1961-1968. doi:10.1111/jce.16007
  3. Data on File. Abbott - Report SJM-CFM-0919-0163.
  4. Shehata MM, Manyam H, Gopinathannair R, et al. Evaluating the Impact of New Arrhythmia Detection Algorithms in an lnsertable Cardiac Monitor. Presented at: Asia Pacific Heart Rhythm Society (APHRS); November 18-20, 2022; Singapore.
  5. Gardner RS, Quartieri F, Betts TR, et al. Reducing the Electrogram Review Burden Imposed by Insertable Cardiac Monitors. Journal of Cardiovascular Electrophysiology. 2022;33(4):741-750. doi:10.1111/jce.15397
  6. Shehata MM, Nair DG, Qu F, et al. Insertable Cardiac Monitor P-wave Visibility in a New Clinical Report. Presented at Asia Pacific Heart Rhythm Society (APHRS); Bangkok Thailand; 2022.
  7. Manyam H, Afzal MR, Gopinathannair R, et al. Evaluation of A Novel Premature Ventricular Contraction Detection Algorithm in an Insertable Cardiac Monitor. Presented at Heart Rhythm Society (HRS); San Francisco, USA; 2022.
  8. Abbott. Assert-IQ™ ICM User Manual. 
  9. Medtronic. REVEAL LINQLNQ11 Insertable Cardiac Monitor and Patient Assistant PA96000 Clinician Manual. Updated January 25, 2022. Accessed February 23, 2024. https://www.medtronic.com/content/dam/emanuals/crdm/M027641C001B_view.pdf
  10. Medtronic. LINQ II‡ LNQ22 Insertable Cardiac Monitor Clinician Manual. Updated October 11, 2022. Accessed February 23, 2024. https://www.medtronic.com/content/dam/emanuals/crdm/M027638C001B_view.pdf
  11. Boston Scientific. User’s Manual, LUX-Dx‡ Insertable Cardiac Monitor System M301, 2925, 2935. Updated May 2022. Accessed February 23, 2024. https://www.bostonscientific.com/content/dam/elabeling/crm/92216690-006_LUX-Dx_ICM_UM_es_S.pdf
  12. Boston Scientific. User’s Manual, LUX-Dx II/II+‡ Insertable Cardiac Monitor System M302, M312, 2925, 2929, 2935, 2939. Updated August 2023. Accessed February 23, 2024. https://www.bostonscientific.com/content/dam/elabeling/crm/51583079-001_LUX-Dx_ICM_UM_en_S.pdf
  13. Biotronik. Technical Manual BIOMONITOR III‡. Updated March 22, 2023. Accessed February 23, 2024. https://manuals.biotronik.com/emanuals-professionals/?country=ES&product=ImplCardMon/BioMonitor3/BioMonitor3
  14. Biotronik. Technical Manual BIOMONITOR IIIm‡. Updated March 22, 2023. Accessed February 23, 2024. https://manuals.biotronik.com/emanuals-professionals/?country=ES&product=ImplCardMon/BioMonitor3m/BioMonitor3m
  15. Biotronik. Technical Manual BIOMONITOR IV‡. Updated December 06, 2023. Accessed February 23, 2024. https://manuals.biotronik.com/emanuals-professionals/?country=ES&product=ImplCardMon/BioMonitor4/BioMonitor4

Additional references

  1. Medtronic. LINQ II‡ LNQ22 Insertable Cardiac Monitor Clinician Manual. Updated October 11, 2022. Accessed February 23, 2024. https://www.medtronic.com/content/dam/emanuals/crdm/M027638C001B_view.pdf
  2. Boston Scientific. User’s Manual, LUX-Dx‡ Insertable Cardiac Monitor System M301, 2925, 2935. Updated May 2022. Accessed February 23, 2024. https://www.bostonscientific.com/content/dam/elabeling/crm/92216690-006_LUX-Dx_ICM_UM_es_S.pdf
  3. Boston Scientific. User’s Manual, LUX-Dx II/II+‡ Insertable Cardiac Monitor System M302, M312, 2925, 2929, 2935, 2939. Updated August 2023. Accessed February 23, 2024. https://www.bostonscientific.com/content/dam/elabeling/crm/51583079-001_LUX-Dx_ICM_UM_en_S.pdf

™ Indicates a trademark of the Abbott group of companies.
 Indicates a third-party trademark, which is property of its respective owner.
Bluetooth and Bluetooth logo are registered trademarks of Bluetooth SIG, Inc.

MAT-2403093 v1.0